Training to improve care and innovation for Alzheimer's disease and related dementias
Official title: IMPRINT - Immersive Methods for Promoting Research and Innovations through Novel Training - for Alzheimer's Disease and Related Dementias
Funded at University of California Berkeley · NIH-10954670 · Data updated 2026-11-12
This friendly program called IMPRINT for ADRD is designed for people interested in improving care for those with Alzheimer's by combining hands-on experiences with learning about business and technology, so together we can find better ways to support patients and their families.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $232,719 |
| NIH project number | 1R25AG088414-01 |
| Project ID | NIH-10954670 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals aged 21 and older who are affected by Alzheimer's disease or related dementias.
✕Less likely to help
Patients who are not affected by Alzheimer's disease or related dementias may not receive any benefit from this research.
What this research studies
This program, known as IMPRINT for ADRD, combines immersive experiences with training in entrepreneurship to enhance understanding and innovation in Alzheimer's care. Participants will learn about the biology and social factors affecting Alzheimer's patients while engaging directly with them in their care environments. The program also explores novel solutions like digital phenotyping and data science tools to improve early detection and prevention of Alzheimer's disease. By integrating patient experiences with technical training, the program aims to develop effective interventions for those affected by Alzheimer's and related dementias.
Why it matters
Potential benefit: If successful, this research could lead to improved care strategies and innovative solutions for individuals living with Alzheimer's disease and related dementias.
How similar studies have gone: Similar approaches that combine immersive learning with patient engagement have shown promise in enhancing care and innovation in other health-related fields.
Where this research is happening
-
University of California Berkeley
Berkeley, United States Active
Researchers
- Principal investigator: Jenkins, Susan — University of California Berkeley
- Study coordinator: Jenkins, Susan
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.